礼来与印度制药商Cipla签署了一项协议,允许后者在印度以独立品牌Yurpeak销售其减肥药。据介绍,Yurpeak将与礼来的Mounjaro Kwikpen一样,以预灌封注射笔的形式出售,使医疗服务提供者能够根据患者的不同需求制定个性化的治疗方案。
礼来与印度制药商Cipla签署了一项协议,允许后者在印度以独立品牌Yurpeak销售其减肥药。据介绍,Yurpeak将与礼来的Mounjaro Kwikpen一样,以预灌封注射笔的形式出售,使医疗服务提供者能够根据患者的不同需求制定个性化的治疗方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.